Category: Kaiser Health News

Ad Targeting Manchin and AARP Mischaracterizes Medicare Drug-Price Negotiations

The advocacy group American Commitment said empowering Medicare to negotiate drug prices would raid it of billions of dollars. Drug pricing experts say that that’s not the case and that such policies would instead reduce costs for the Medicare program and seniors.

Three Things About the Abortion Debate That Many People Get Wrong

The commonly repeated myths include arguments that only women who are pregnant are affected by the decision overturning Roe v. Wade, that Democratic lawmakers could have codified abortion protections before, and that Congress can easily get rid of federal laws restricting abortion.

A Nearly Century-Old Maternity Home for Teens in the South Makes Plans for Expansion

Homes for pregnant girls may seem like a vestige of the past. But they still exist and, in light of the Supreme Court’s recent ruling on abortion, may become more necessary.

KHN’s ‘What the Health?’: Drug Price Bill Is a Go in the Senate

Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.

Parents Become Drug Developers to Save Their Children’s Lives

Families affected by ultra-rare diseases are starting their own companies to speed the development of treatments for their kids, venturing into territory that traditional drugmakers deem too risky.

‘So Rudderless’: A Couple’s Quest for Autism Treatment for Their Son Hits Repeated Obstacles

Amparo and Victor Rios began searching for answers about their son’s development when he didn’t hit some milestones after turning 2. Three years later, they are still trying to get their insurance to pay for expensive therapy to help him.

Watch: Why the Public Health System Is Having Trouble Containing Monkeypox

KHN Midwest correspondent Lauren Weber appeared on CBS News’ streaming network to discuss “Fighting Monkeypox, Sexual Health Clinics Are Underfunded and Ill-Equipped,” an article she wrote with KHN senior correspondent Liz Szabo. It details how ill-equipped the nation’s sexual health clinics and public health system are to tackle monkeypox after decades of underfunding. Weber described […]

Critics Worry Government Surveillance of HIV May Hurt More Than It Helps

Some people living with HIV and some state health officials are raising concerns about part of the federal effort to end the HIV epidemic: a new technology that analyzes blood samples to find emerging outbreaks. The critics say it’s too invasive and stigmatizing and might not be more effective than older public health approaches.

In Some States, Voters Will Get to Decide the Future of Abortion Rights

Measures to enshrine the right to abortion in the state constitution will be on the ballot in California and Vermont this fall. Abortion-rights advocates in Michigan are hoping their state will follow suit.

No-Bid Medicaid Contract for Kaiser Permanente Is Now California Law, but Key Details Are Missing

California Gov. Gavin Newsom signed a bill last month that authorizes a statewide Medicaid contract for HMO giant Kaiser Permanente. But details still need to be worked out in a memorandum of understanding.